Skip to main content

Andy Doraiswamy

October 12, 2022

A UNC Chapel Hill Ph.D. graduate who is the founder and CEO of Koya Medical, a team dedicated to transforming chronic lymphatic and venous disease. Andy also serves as Chairman and board director with an eye-care and urology health venture. Previously, he led Oculeve, a first-in-class healthcare venture funded by NEA, KPCB, and Versant to treat ocular disorders with a revolutionary neuromodulation platform. Oculeve was acquired by Allergan Plc.

Brian Miller

October 12, 2022

Brian Miller, M.D., M.B.A., M.P.H. is an Assistant Professor of Medicine and Business (courtesy) at the Johns Hopkins University, where he is a practicing hospitalist, health policy researcher, and health policy analyst. He is a consultant to the FTC Bureau of Consumer Protection on health insurance and is a member of the Medicare Evidence Development & Coverage Advisory Committee.

Peter Johnson

October 12, 2022

Peter C. Johnson, M.D., is the president and CEO of Scintellix, LLC, a biomedical technology consulting company in Raleigh, NC and the VP, R&D and Medical and Scientific Affairs, Vancive Medical Technologies – an Avery Dennison business.